Duration varies by individual
The peptide stimulates endogenous GH production rather than suppressing it, so the hypothalamic-pituitary axis is not shut down in the way it would be with exogenous hormone administration
The cleanest decision rule: stay on it as long as your fasting insulin, HOMA-IR, and cycle stay in the range you and your clinician are aiming for and revisit the question every 12 months
So while momentum has shifted slightly toward our side, Im still skeptical this plays out as a net positive for peptide access overall. If all this still feels confusing and murky to wade through, the most important thing to remember is that most peptides continue to be unregulated and do not have adequate safety data behind themand that a compounded peptide is not the same thing as an FDA-approved medication
KLOW is commonly framed as an extension of Glow or Wolverine blends, usually by adding the tripeptide KPV to GHK-Cu, BPC-157 and TB-500
Until then, Mexico remains one of the most accessible and cost-effective options for Americans seeking affordable GLP-1 therapy